Current role
Biotechnology · Healthcare
Chairman, Board Member
2023-11-01–present
Thomas G. Wiggans
Chairman
Jasper Therapeutics, Inc. (JSPR)Board Member
Jasper Therapeutics, Inc. (JSPR)Equibles does not estimate personal net worth.
Get an email with a short summary when Jasper Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get JSPR alertsAbout Thomas G. Wiggans
Thomas G. Wiggans is recorded as Chairman at Jasper Therapeutics, Inc. (JSPR) since January 5, 2026 and Board Member at Jasper Therapeutics, Inc. (JSPR) since November 1, 2023. Jasper Therapeutics, Inc. reported in an 8-K filed January 7, 2026 that Thomas G. Wiggans was appointed Executive Chair, effective January 5, 2026. Jasper Therapeutics, Inc. reported in an 8-K filed November 1, 2023 that Thomas G. Wiggans was appointed Chairperson of the Board, effective November 1, 2023. Jasper Therapeutics, Inc. reported in an 8-K filed November 1, 2023 that Thomas G. Wiggans was appointed Class II director, effective November 1, 2023. Jasper Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Jasper Therapeutics, Inc. includes Jeet Mahal (CEO, COO and Board Member), Ronald Martell (CEO and Board Member), William Lis (CEO) and 7 others.
“Effective January 5, 2026, the Board appointed Thomas G. Wiggans, current Chairperson of the Board, as the Company's Executive Chair.”
“Mr. Wiggans was also appointed to serve as Chairperson of the Board.”
Affiliation history
-
Current
2026-01-05–present
-
Current
2023-11-01–present
Company network
Leadership on record at Jasper Therapeutics, Inc.
- Jeet Mahal CEO, COO, Board Member
- Ronald Martell CEO, Board Member
- William Lis CEO
- Howard Hoffen Chairman
- Matthew Ros COO, General Counsel
- Rick Ruiz Chief Accounting Officer
- Anna French, D. Phil. Board Member
- Christian W. Nolet Board Member
- Judith Shizuru, M.D., Ph.D. Board Member
- Kurt von Emster Board Member